ClinicalTrials.Veeva

Menu

NC Xperience PMCF Study( rEPIC04B)

F

Fundación EPIC

Status

Completed

Conditions

Ischemic Heart Disease
Coronary Artery Disease (CAD)

Treatments

Device: NC Xperience

Study type

Observational

Funder types

Other

Identifiers

NCT05292105
NC Xperience PMCF Study

Details and patient eligibility

About

Multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study to confirm and support the clinical safety and performance of NC Xperience to meet EU Medical Device regulation (MDR) requirements in all the CONSECUTIVE patients treated with NC Xperience .

Full description

The objective of this multicenter, prospective, non-randomized, post-market clinical follow-up (PMCF) study is to confirm and support the clinical safety and performance of the NC Xperience in a NON-SELECTED, Real World population under daily clinical practice when used as intended by the manufacturer to meet EU Medical Device regulation requirements for post-market clinical follow-up.

Enrollment

59 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patient treated with NC Xperience according to routine hospital practice and following instructions for use
  • Informed consent signed

Exclusion criteria

  • Not meet inclusion criteria

Trial design

59 participants in 1 patient group

Coronary Artery Disease (CAD)
Treatment:
Device: NC Xperience

Trial contacts and locations

3

Loading...

Central trial contact

FUNDACION EPIC; FUNDACION EPIC

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems